Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake.

Christensen BC, Kelsey KT, Zheng S, Houseman EA, Marsit CJ, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Kushi LH, Kwan ML, Wiencke JK.

PLoS Genet. 2010 Jul 29;6(7):e1001043. doi: 10.1371/journal.pgen.1001043.


Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women.

Sellers TA, Vierkant RA, Cerhan JR, Gapstur SM, Vachon CM, Olson JE, Pankratz VS, Kushi LH, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1104-7.


Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.

Conway K, Edmiston SN, Tse CK, Bryant C, Kuan PF, Hair BY, Parrish EA, May R, Swift-Scanlan T.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):921-30. doi: 10.1158/1055-9965.EPI-14-1228. Epub 2015 Mar 25.


Alcohol and dietary folate intake and the risk of breast cancer: a case-control study in Japan.

Islam T, Ito H, Sueta A, Hosono S, Hirose K, Watanabe M, Iwata H, Tajima K, Tanaka H, Matsuo K.

Eur J Cancer Prev. 2013 Jul;22(4):358-66. doi: 10.1097/CEJ.0b013e32835b6a60.


Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma.

Avissar-Whiting M, Koestler DC, Houseman EA, Christensen BC, Kelsey KT, Marsit CJ.

Epigenetics. 2011 Jun;6(6):703-9. Epub 2011 Jun 1.


CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.

Dietrich D, Krispin M, Dietrich J, Fassbender A, Lewin J, Harbeck N, Schmitt M, Eppenberger-Castori S, Vuaroqueaux V, Spyratos F, Foekens JA, Lesche R, Martens JW.

BMC Cancer. 2010 Jun 1;10:247. doi: 10.1186/1471-2407-10-247.


Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes.

Zhu K, Davidson NE, Hunter S, Yang X, Payne-Wilks K, Roland CL, Phillips D, Bentley C, Dai M, Williams SM.

Cancer Causes Control. 2003 Nov;14(9):827-36.


Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity.

Hill VK, Ricketts C, Bieche I, Vacher S, Gentle D, Lewis C, Maher ER, Latif F.

Cancer Res. 2011 Apr 15;71(8):2988-99. doi: 10.1158/0008-5472.CAN-10-4026. Epub 2011 Mar 1. Erratum in: Cancer Res. 2012 Jun 15;72(12):3115.


DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer.

Wilhelm-Benartzi CS, Koestler DC, Houseman EA, Christensen BC, Wiencke JK, Schned AR, Karagas MR, Kelsey KT, Marsit CJ.

Carcinogenesis. 2010 Nov;31(11):1972-6. doi: 10.1093/carcin/bgq178. Epub 2010 Aug 28.


Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.

Fackler MJ, Umbricht CB, Williams D, Argani P, Cruz LA, Merino VF, Teo WW, Zhang Z, Huang P, Visvananthan K, Marks J, Ethier S, Gray JW, Wolff AC, Cope LM, Sukumar S.

Cancer Res. 2011 Oct 1;71(19):6195-207. doi: 10.1158/0008-5472.CAN-11-1630. Epub 2011 Aug 8.


DNA methylation and hormone receptor status in breast cancer.

Benevolenskaya EV, Islam AB, Ahsan H, Kibriya MG, Jasmine F, Wolff B, Al-Alem U, Wiley E, Kajdacsy-Balla A, Macias V, Rauscher GH.

Clin Epigenetics. 2016 Feb 16;8:17. doi: 10.1186/s13148-016-0184-7. eCollection 2016.


Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.

Pirouzpanah S, Taleban FA, Mehdipour P, Atri M.

J Mol Med (Berl). 2015 Aug;93(8):917-34. doi: 10.1007/s00109-015-1268-0. Epub 2015 Mar 25.


Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, Fournier A, Hankinson SE, Henderson BE, Hoover RN, Isaacs C, Johansson M, Kolonel LN, Kraft P, Lee IM, McCarty CA, Overvad K, Panico S, Peeters PH, Riboli E, Sanchez MJ, Schumacher FR, Skeie G, Stram DO, Thun MJ, Trichopoulos D, Zhang S, Ziegler RG, Hunter DJ, Lindström S, Canzian F.

J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63. doi: 10.1093/jnci/djr265. Epub 2011 Jul 26.


Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors.

Abdel-Maksoud MF, Risendal BC, Slattery ML, Giuliano AR, Baumgartner KB, Byers TE.

Breast Cancer Res Treat. 2012 Jan;131(1):169-76. doi: 10.1007/s10549-011-1705-x. Epub 2011 Aug 6.


Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors.

Hair BY, Troester MA, Edmiston SN, Parrish EA, Robinson WR, Wu MC, Olshan AF, Swift-Scanlan T, Conway K.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):580-6. doi: 10.1158/1055-9965.EPI-14-1017. Epub 2015 Jan 12.


Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study.

Lew JQ, Freedman ND, Leitzmann MF, Brinton LA, Hoover RN, Hollenbeck AR, Schatzkin A, Park Y.

Am J Epidemiol. 2009 Aug 1;170(3):308-17. doi: 10.1093/aje/kwp120. Epub 2009 Jun 18.


Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.

Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, Huang W, Shao ZM.

Hum Pathol. 2010 Jan;41(1):48-58. doi: 10.1016/j.humpath.2009.06.007. Epub 2009 Sep 5.


DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.

Zhang M, Zhang S, Wen Y, Wang Y, Wei Y, Liu H, Zhang D, Su J, Wang F, Zhang Y.

PLoS One. 2015 Nov 9;10(11):e0142279. doi: 10.1371/journal.pone.0142279. eCollection 2015.


Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors.

Klajic J, Fleischer T, Dejeux E, Edvardsen H, Warnberg F, Bukholm I, Lønning PE, Solvang H, Børresen-Dale AL, Tost J, Kristensen VN.

BMC Cancer. 2013 Oct 5;13:456. doi: 10.1186/1471-2407-13-456.

Supplemental Content

Support Center